Literature DB >> 12150769

Parkinson's disease, Alzheimer's disease and motor neurone disease: identifying a common mechanism.

S Greenfield1, D J Vaux.   

Abstract

Although Alzheimer's disease, Parkinson's disease, and motor neurone disease are distinct disorders, there could be a common neurodegenerative mechanism that characterises the death of selective neurone populations in each case. We propose that this mechanism could be an aberrantly activated, developmental process involving a non-classical, non-enzymatic action of acetylcholinesterase mediated via a short linear motif near the C-terminal end of the molecule. Since this motif has a highly conserved homology with part of the amyloid precursor protein, it may be particularly attractive as a target for novel therapeutic strategies in neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12150769     DOI: 10.1016/s0306-4522(02)00194-x

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  21 in total

Review 1.  Neuronal AChE splice variants and their non-hydrolytic functions: redefining a target of AChE inhibitors?

Authors:  M Zimmermann
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

2.  An Alternative Approach to Study Primary Events in Neurodegeneration Using Ex Vivo Rat Brain Slices.

Authors:  Emanuele Brai; Antonella Cogoni; Susan A Greenfield
Journal:  J Vis Exp       Date:  2018-04-11       Impact factor: 1.355

3.  Optical imaging of the rat brain suggests a previously missing link between top-down and bottom-up nervous system function.

Authors:  Susan A Greenfield; Antoine-Scott Badin; Giovanni Ferrati; Ian M Devonshire
Journal:  Neurophotonics       Date:  2017-05-24       Impact factor: 3.593

4.  Bioactivity of a peptide derived from acetylcholinesterase in hippocampal organotypic cultures.

Authors:  T Day; S A Greenfield
Journal:  Exp Brain Res       Date:  2003-12-18       Impact factor: 1.972

Review 5.  Acetylcholinesterase in Hirschsprung's disease.

Authors:  S W Moore; G Johnson
Journal:  Pediatr Surg Int       Date:  2005-03-10       Impact factor: 1.827

Review 6.  Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.

Authors:  Paul C Trippier; Kristin Jansen Labby; Dustin D Hawker; Jan J Mataka; Richard B Silverman
Journal:  J Med Chem       Date:  2013-03-27       Impact factor: 7.446

7.  Glioprotective Effects of Lingonberry Extract Against Altered Cellular Viability, Acetylcholinesterase Activity, and Oxidative Stress in Lipopolysaccharide-Treated Astrocytes.

Authors:  Simone Muniz Pacheco; Juliana Hofstätter Azambuja; Taíse Rosa de Carvalho; Mayara Sandrielly Pereira Soares; Pathise Souto Oliveira; Elita Ferreira da Silveira; Francieli Moro Stefanello; Elizandra Braganhol; Jessié Martins Gutierres; Roselia Maria Spanevello
Journal:  Cell Mol Neurobiol       Date:  2018-03-19       Impact factor: 5.046

8.  Conformational preferences of a 14-residue fibrillogenic peptide from acetylcholinesterase.

Authors:  Ranjit Vijayan; Philip C Biggin
Journal:  Biochemistry       Date:  2010-05-04       Impact factor: 3.162

9.  A peptide derived from acetylcholinesterase induces neuronal cell death: characterisation of possible mechanisms.

Authors:  T Day; S A Greenfield
Journal:  Exp Brain Res       Date:  2003-09-06       Impact factor: 1.972

10.  Upregulation of alpha7 Nicotinic Receptors by Acetylcholinesterase C-Terminal Peptides.

Authors:  Cherie E Bond; Martina Zimmermann; Susan A Greenfield
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.